Khiron Probability Of Bankruptcy

KHRWF -  USA Stock  

USD 0.1  0.0026  2.76%

Khiron Life Sciences Probability Of Bankruptcy is used to show its chance of financial distress over the next two years of operations under current economic and market conditions. Khiron Life Sciences Probability Of Bankruptcy is determined by interpolating and adjusting Khiron Altman Z Score to account for off-balance-sheet items and missing or unfiled public information. All items used in analyzing the odds of distress are taken from the Khiron balance sheet as well as cash flow and income statements available from the company's most recent filings. Please see Khiron Life Piotroski F Score and Khiron Life Altman Z Score analysis.

Khiron Probability Of Bankruptcy 

 
Refresh

Khiron Probability Of Bankruptcy Analysis

Khiron Life's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Probability Of Bankruptcy 
 = 
Normalized 
 
Z-Score 
More About Probability Of Bankruptcy | All Equity Analysis

Current Khiron Life Probability Of Bankruptcy

    
  73%  
Most of Khiron Life's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Khiron Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of Khiron Life probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Khiron Life odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Khiron Life Sciences financial health.
The market value of Khiron Life Sciences is measured differently than its book value, which is the value of Khiron that is recorded on the company's balance sheet. Investors also form their own opinion of Khiron Life's value that differs from its market value or its book value, called intrinsic value, which is Khiron Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Khiron Life's market value can be influenced by many factors that don't directly affect Khiron Life Sciences underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Khiron Life's value and its price as these two are different measures arrived at by different means. Investors typically determine Khiron Life value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Khiron Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
Compare to competition
Based on the latest financial disclosure, Khiron Life Sciences has a Probability Of Bankruptcy of 73%. This is much higher than that of the sector and significantly higher than that of the Probability Of Bankruptcy industry. The probability of bankruptcy for all United States stocks is notably lower than that of the firm.

Khiron Probability Of Bankruptcy Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Khiron Life's direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Khiron Life could also be used in its relative valuation, which is a method of valuing Khiron Life by comparing valuation metrics of similar companies.
Khiron Life is currently under evaluation in probability of bankruptcy category among related companies.

Khiron Fundamentals

About Khiron Life Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Khiron Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Khiron Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Khiron Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Khiron Life Sciences Corp. operates as an integrated cannabis company in Latin America, North America, and Europe. Khiron Life Sciences Corp. was founded in 2017 and is based in Vancouver, Canada. Khiron Life is traded on OTC Exchange in the United States.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Khiron Life without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Focused Opportunities Now

   

Focused Opportunities

Build portfolios using our predefined set of ideas and optimize them against your investing preferences
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Khiron Life Sciences using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Khiron Life Piotroski F Score and Khiron Life Altman Z Score analysis. Note that the Khiron Life Sciences information on this page should be used as a complementary analysis to other Khiron Life's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.

Complementary Tools for Khiron OTC Stock analysis

When running Khiron Life Sciences price analysis, check to measure Khiron Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Khiron Life is operating at the current time. Most of Khiron Life's value examination focuses on studying past and present price action to predict the probability of Khiron Life's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Khiron Life's price. Additionally, you may evaluate how the addition of Khiron Life to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
The market value of Khiron Life Sciences is measured differently than its book value, which is the value of Khiron that is recorded on the company's balance sheet. Investors also form their own opinion of Khiron Life's value that differs from its market value or its book value, called intrinsic value, which is Khiron Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Khiron Life's market value can be influenced by many factors that don't directly affect Khiron Life Sciences underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Khiron Life's value and its price as these two are different measures arrived at by different means. Investors typically determine Khiron Life value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Khiron Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.